Literature DB >> 21705880

Pregnancy-induced progression of keratoconus.

Kamil Bilgihan1, Ahmet Hondur, Sabahattin Sul, Sertac Ozturk.   

Abstract

PURPOSE: To report eyes with keratoconus that progressed during pregnancy.
METHODS: Seven eyes of 4 patients with progression of keratoconus during pregnancy were included in this study. The mean age of patients and the mean follow-up duration were 29.3 years and 39 months, respectively. Progressive keratoconus was documented with changes in refraction, corneal topography, and rigid gas-permeable lens fitting pattern. Patients with accompanying systemic and ocular diseases associated with keratoconus, uncontrolled atopic disease, and eye rubbing were excluded.
RESULTS: Mean increase in spherical equivalent refraction and simulated keratometry values were 1.4 ± 1.1 and 1.1 ± 0.8 diopters, respectively. In eyes wearing rigid gas-permeable lenses, increase in corneal apical touch and decrease in the base curve radius of the best-fitting contact lens were observed.
CONCLUSIONS: Hormonal changes during pregnancy may affect corneal biomechanics negatively, and pregnancy may be a previously unrecognized risk factor for progression of keratoconus. To our knowledge, this is the first study showing pregnancy-induced keratoconus progression in patients with no accompanying disease.

Entities:  

Mesh:

Year:  2011        PMID: 21705880     DOI: 10.1097/ICO.0b013e3182068adc

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  23 in total

Review 1.  Keratoconus: an inflammatory disorder?

Authors:  V Galvis; T Sherwin; A Tello; J Merayo; R Barrera; A Acera
Journal:  Eye (Lond)       Date:  2015-05-01       Impact factor: 3.775

Review 2.  [Histological changes in keratoconus and wound healing after corneal cross-linking].

Authors:  Louisa M Bulirsch; Constance Weber; Marlene Saßmannshausen; Markus Kohlhaas; Frank G Holz; Karin U Loeffler; Martina C Herwig-Carl
Journal:  Ophthalmologe       Date:  2021-12-07       Impact factor: 1.059

3.  Anterior pituitary, sex hormones, and keratoconus: Beyond traditional targets.

Authors:  Dimitrios Karamichos; Paulina Escandon; Brenda Vasini; Sarah E Nicholas; Lyly Van; Deanna H Dang; Rebecca L Cunningham; Kamran M Riaz
Journal:  Prog Retin Eye Res       Date:  2021-11-02       Impact factor: 19.704

4.  The effect of estrogen and progesterone on porcine corneal biomechanical properties.

Authors:  Eyal Walter; Ran Matlov Kormas; Arie L Marcovich; Yotam Lior; Xiaomeng Sui; Daniel Wagner; Boris Knyazer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-10-17       Impact factor: 3.117

Review 5.  Current review and a simplified "five-point management algorithm" for keratoconus.

Authors:  Rohit Shetty; Luci Kaweri; Natasha Pahuja; Harsha Nagaraja; Kareeshma Wadia; Chaitra Jayadev; Rudy Nuijts; Vishal Arora
Journal:  Indian J Ophthalmol       Date:  2015-01       Impact factor: 1.848

Review 6.  Molecular and Histopathological Changes Associated with Keratoconus.

Authors:  Mariam Lotfy Khaled; Inas Helwa; Michelle Drewry; Mutsa Seremwe; Amy Estes; Yutao Liu
Journal:  Biomed Res Int       Date:  2017-01-30       Impact factor: 3.411

Review 7.  Ocular changes during pregnancy.

Authors:  Mohammad Naderan
Journal:  J Curr Ophthalmol       Date:  2018-01-03

8.  Hypothyroidism is Not Associated with Keratoconus Disease: Analysis of 626 Subjects.

Authors:  Zsuzsa Flaskó; Elena Zemova; Timo Eppig; László Módis; Achim Langenbucher; Stefan Wagenpfeil; Berthold Seitz; Nóra Szentmáry
Journal:  J Ophthalmol       Date:  2019-10-31       Impact factor: 1.909

Review 9.  Pathogenesis of Keratoconus: The intriguing therapeutic potential of Prolactin-inducible protein.

Authors:  Rabab Sharif; Sashia Bak-Nielsen; Jesper Hjortdal; Dimitrios Karamichos
Journal:  Prog Retin Eye Res       Date:  2018-07-13       Impact factor: 19.704

10.  Keratoconus progression associated with hormone replacement therapy.

Authors:  Giulia Coco; Ahmad Kheirkhah; William Foulsham; Reza Dana; Joseph B Ciolino
Journal:  Am J Ophthalmol Case Rep       Date:  2019-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.